Diagnosis and prevention of chronic kidney allograft loss

[1]  R. Gaston,et al.  Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[2]  Jeff Reeve,et al.  A molecular classifier for predicting future graft loss in late kidney transplant biopsies. , 2010, The Journal of clinical investigation.

[3]  Steve Doucette,et al.  Treatment of Polyomavirus Infection in Kidney Transplant Recipients: A Systematic Review , 2010, Transplantation.

[4]  M. Mengel.  The kidney transplant: new horizons , 2010, Current opinion in nephrology and hypertension.

[5]  M. Sarwal,et al.  Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. , 2010, Journal of the American Society of Nephrology : JASN.

[6]  L C Racusen,et al.  Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  S. Doucette,et al.  Estimating glomerular filtration rate in kidney transplantation: is the new chronic kidney disease epidemiology collaboration equation any better? , 2010, Clinical chemistry.

[8]  R. Colvin,et al.  Tubular expression of KIM-1 does not predict delayed function after transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[9]  Ethan M Balk,et al.  KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.

[10]  M. Stegall,et al.  Deciphering antibody-mediated rejection: new insights into mechanisms and treatment , 2010, Current Opinion in Organ Transplantation.

[11]  S. Quaglini,et al.  Long‐term outcome of renal transplantation in adults with focal segmental glomerulosclerosis , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[12]  B. Kasiske,et al.  Pathological and Clinical Characterization of the ‘Troubled Transplant’: Data from the DeKAF Study , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  A. Cherukuri,et al.  The Clinical Significance of Early Proteinuria After Renal Transplantation , 2010, Transplantation.

[14]  A. Webster,et al.  Interleukin 2 receptor antagonists for kidney transplant recipients. , 2010, The Cochrane database of systematic reviews.

[15]  S. Knight,et al.  Steroid Avoidance or Withdrawal After Renal Transplantation Increases the Risk of Acute Rejection but Decreases Cardiovascular Risk. A Meta-Analysis , 2010, Transplantation.

[16]  David G Camp,et al.  Shotgun proteomics identifies proteins specific for acute renal transplant rejection , 2010, Proteomics. Clinical applications.

[17]  A. Ojo,et al.  The alphabet soup of kidney transplantation: SCD, DCD, ECD--fundamentals for the practicing nephrologist. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[18]  G. Jhangri,et al.  Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody‐Mediated Damage Despite Lack of C4d Staining , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  A. Torres,et al.  A Novel Risk Score for Mortality in Renal Transplant Recipients Beyond the First Posttransplant Year , 2009, Transplantation.

[20]  A. Arjona.  Soluble CD30 for the prediction and detection of kidney transplant rejection. , 2009, Drug news & perspectives.

[21]  W. Weimar,et al.  Successful Expansion of the Living Donor Pool by Alternative Living Donation Programs , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  P. Terasaki,et al.  HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft Loss , 2009, Transplantation.

[23]  G. Jhangri,et al.  Scoring Total Inflammation Is Superior to the Current Banff Inflammation Score in Predicting Outcome and the Degree of Molecular Disturbance in Renal Allografts , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  M. Hattori,et al.  Screening of vesicoureteral reflux in pediatric patients with kidney transplantation showing non‐specific interstitial fibrosis and tubular atrophy with interstitial Tamm–Horsfall protein deposits in protocol allograft biopsy , 2009, Clinical transplantation.

[25]  Douglas E Schaubel,et al.  A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk Index , 2009, Transplantation.

[26]  A. Webster,et al.  Antihypertensives for Kidney Transplant Recipients: Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2009, Transplantation.

[27]  P. Aljama,et al.  Achieving Chronic Kidney Disease Treatment Targets in Renal Transplant Recipients: Results From a Cross-Sectional Study in Spain , 2009, Transplantation.

[28]  M. Cavazzana‐Calvo,et al.  Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  S. Knight,et al.  Mycophenolate Mofetil Decreases Acute Rejection and may Improve Graft Survival in Renal Transplant Recipients When Compared with Azathioprine: A Systematic Review , 2009, Transplantation.

[30]  M. Stegall,et al.  Identifying Specific Causes of Kidney Allograft Loss , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  D. Adu,et al.  Calcineurin Inhibitor Sparing With Mycophenolate in Kidney Transplantation: A Systematic Review and Meta-Analysis , 2009, Transplantation.

[32]  P. Cockwell,et al.  Comparison of the Predictive Performance of eGFR Formulae for Mortality and Graft Failure in Renal Transplant Recipients , 2009, Transplantation.

[33]  Minnie Sarwal,et al.  Calcineurin Inhibitor Nephrotoxicity , 2012 .

[34]  F. Schena,et al.  Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial , 2009, Transplantation.

[35]  F. Dobbels,et al.  Nonadherence Consensus Conference Summary Report , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  S. Bunnapradist,et al.  Impact of gastrointestinal‐related side effects on mycophenolate mofetil dosing and potential therapeutic strategies , 2008, Clinical transplantation.

[37]  J. Pascual,et al.  A systematic review of kidney transplantation from expanded criteria donors. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  B. Iványi.  A primer on recurrent and de novo glomerulonephritis in renal allografts , 2008, Nature Clinical Practice Nephrology.

[39]  M. Suthanthiran,et al.  Noninvasive Prediction of Organ Graft Rejection and Outcome Using Gene Expression Patterns , 2008, Transplantation.

[40]  F. Moreso,et al.  Fluvastatin in the Prevention of Renal Transplant Vasculopathy: Results of a Prospective, Randomized, Double-Blind, Placebo-Controlled Trial , 2008, Transplantation.

[41]  P. Nickel,et al.  Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. , 2008, Journal of the American Society of Nephrology : JASN.

[42]  G. Knoll,et al.  Performance of creatinine-based estimates of GFR in kidney transplant recipients: a systematic review. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  A. Henning,et al.  Conversion From Cyclosporine to Tacrolimus in Patients at Risk for Chronic Renal Allograft Failure: 60-Month Results of the CRAF Study , 2008, Transplantation.

[44]  B. Howden,et al.  Long-Term Cardiac Allograft Survival across an MHC Mismatch after “Pruning” of Alloreactive CD4 T Cells1 , 2008, The Journal of Immunology.

[45]  P. Halloran,et al.  Reduced exposure to calcineurin inhibitors in renal transplantation. , 2007, The New England journal of medicine.

[46]  J. Buscombe,et al.  Late Recurrent Urinary Tract Infections May Produce Renal Allograft Scarring Even in the Absence of Symptoms or Vesicoureteric Reflux , 2007, Transplantation.

[47]  M. Salifu,et al.  Hypertension After Renal Transplant , 2007, Journal of clinical hypertension.

[48]  G. Klintmalm,et al.  Calcineurin inhibitor‐sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity , 2007, Clinical transplantation.

[49]  G. Russ,et al.  Kidney Transplant Rejection in Australia and New Zealand: Relationships Between Rejection and Graft Outcome , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[50]  U. Udayaraj,et al.  Chronic Renal Failure in Kidney Transplant Recipients. Do They Receive Optimum Care?: Data from the UK Renal Registry , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[51]  R. Colvin.  Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. , 2007, Journal of the American Society of Nephrology : JASN.

[52]  R. Colvin,et al.  Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’) , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[53]  M. McBride,et al.  Early Mortality Rates in Older Kidney Recipients With Comorbid Risk Factors , 2007, Transplantation.

[54]  D. Schaubel,et al.  Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[55]  E. Reed,et al.  Assessing Relative Risks of Infection and Rejection: A Meta-analysis using an Immune Function Assay , 2006, Transplantation.

[56]  J. Chapman,et al.  The Significance of Subclinical Rejection and the Value of Protocol Biopsies , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[57]  D. Wishart,et al.  Transplant Glomerulopathy, Late Antibody‐Mediated Rejection and the ABCD Tetrad in Kidney Allograft Biopsies for Cause , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[58]  W. Padberg,et al.  Post‐Transplant sCD30 and Neopterin as Predictors of Chronic Allograft Nephropathy: Impact of Different Immunosuppressive Regimens , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[59]  J. Chapman,et al.  Chronic Allograft Nephropathy: Current Concepts and Future Directions , 2006, Transplantation.

[60]  G. Heinze,et al.  Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. , 2006, Journal of the American Society of Nephrology : JASN.

[61]  G. Navis,et al.  The Predictive Value of Renal Vascular Resistance for Late Renal Allograft Loss , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[62]  V. Sharma,et al.  Messenger RNA for FOXP3 in the urine of renal-allograft recipients. , 2005, The New England journal of medicine.

[63]  T. Larson,et al.  Predicting Subsequent Decline in Kidney Allograft Function from Early Surveillance Biopsies , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[64]  A. Webster,et al.  Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data , 2005, BMJ : British Medical Journal.

[65]  M. Copin,et al.  Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial. , 2005, Journal of the American Society of Nephrology : JASN.

[66]  Anke Schwarz,et al.  Safety and Adequacy of Renal Transplant Protocol Biopsies , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[67]  D. Abramowicz,et al.  Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study. , 2005, Journal of the American Society of Nephrology : JASN.

[68]  C. Dudley,et al.  Mycophenolate Mofetil Substitution for Cyclosporine A in Renal Transplant Recipients with Chronic Progressive Allograft Dysfunction: The “Creeping Creatinine” Study1 , 2005, Transplantation.

[69]  Philip F Halloran,et al.  Immunosuppressive drugs for kidney transplantation. , 2004, The New England journal of medicine.

[70]  W. Baldwin,et al.  Antibody, complement and accommodation in ABO-incompatible transplants. , 2004, Current opinion in immunology.

[71]  J. Chapman,et al.  Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology , 2004, Transplantation.

[72]  J. Schold,et al.  Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies? , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[73]  T. Paavonen,et al.  Sirolimus‐Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 Years , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[74]  P. Roderick,et al.  Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review , 2004, Transplantation.

[75]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[76]  H. Meier‐Kriesche,et al.  Poor Predictive Value of Serum Creatinine for Renal Allograft Loss , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[77]  R. Wolfe,et al.  Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.

[78]  A. Schwarz,et al.  The renal arterial resistance index and renal allograft survival. , 2003, The New England journal of medicine.

[79]  M. Zeier,et al.  The effect of donor gender on graft survival. , 2002, Journal of the American Society of Nephrology : JASN.

[80]  E. Briganti,et al.  Risk of renal allograft loss from recurrent glomerulonephritis. , 2002, The New England journal of medicine.

[81]  B. Kasiske,et al.  A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[82]  Grebe So,et al.  Immune monitoring in organ transplantation using neopterin. , 2002 .

[83]  M. Suthanthiran,et al.  Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. , 2001, The New England journal of medicine.

[84]  J. Chapman,et al.  Diagnosis of kidney transplant obstruction using Mag3 diuretic renography , 2001, Clinical transplantation.

[85]  M. Flynn,et al.  Medication Noncompliance and its Implications in Transplant Recipients , 2012, Drugs.

[86]  C. Parikh,et al.  IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[87]  Jean-Paul Squifflet,et al.  Machine perfusion or cold storage in deceased-donor kidney transplantation. , 2009, The New England journal of medicine.

[88]  S. Değer,et al.  Outcomes of transplanting deceased-donor kidneys between elderly donors and recipients. , 2009, Journal of the American Society of Nephrology : JASN.

[89]  A. Waaga,et al.  The influence of donor brain death on short and long-term outcome of solid organ allografts. , 2000, Annals of transplantation.